High drug load formulations and dosage forms

Details for Australian Patent Application No. 2006272760 (hide)

Owner Myriad Genetics, Inc.

Inventors Zentner, Gaylen M.; Powers, Tracy Annette; Oehrtman, Gregory T.; Williams, Mark S.; McRea, James C.

Agent Peter Maxwell & Associates

Pub. Number AU-A-2006272760

PCT Pub. Number WO2007/014124

Priority 60/701,710 22.07.05 US; 60/706,344 08.08.05 US

Filing date 24 July 2006

Wipo publication date 1 February 2007

International Classifications

A61K 31/13 (2006.01) - Amines, e.g. amantadine

Event Publications

31 January 2008 PCT application entered the National Phase

  PCT publication WO2007/014124 Priority application(s): WO2007/014124

10 March 2011 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(c). A direction to request examination has been given for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006272766-Near infrared microbial elimination laser system (NIMELS)

2006272759-Compositions and methods of treating disease with FGFR fusion proteins